Triton Fundus Autofluorescence and Fluorescein Angiography
Launched by TOPCON MEDICAL SYSTEMS, INC. · Apr 4, 2017
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
The objectives of this study are to:
1. Compare the image quality of the fundus autofluorescence (FAF) photographs between DRI OCT Triton (plus) and TRC-50DX retinal camera.
2. Compare the image quality of the fluorescein angiography (FA) photographs between DRI OCT Triton (plus) and TRC-50DX retinal camera.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • 1. Subjects must be at least 18 years of age
- • 2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent
- • 3. Subjects who consent to, via clinic's standard FA consent form, and will undergo dye injection for FA imaging at the clinic visit based on medical need
- • Exclusion Criteria
- • 1. Subjects unable to tolerate ophthalmic imaging
- • 2. Subjects with ocular media not sufficiently clear to obtain acceptable fundus images
- • 3. Patients with ocular motility dysfunction
About Topcon Medical Systems, Inc.
Topcon Medical Systems, Inc. is a leading provider of advanced ophthalmic equipment and technology, dedicated to enhancing the diagnosis and treatment of eye care conditions. With a commitment to innovation and quality, Topcon develops a comprehensive range of diagnostic instruments and software solutions that empower eye care professionals to deliver superior patient care. The company actively engages in clinical trials to advance the field of ophthalmology, ensuring that their products meet the highest standards of efficacy and safety. Through collaboration with healthcare providers and researchers, Topcon aims to improve patient outcomes and drive advancements in vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Charles Riesman, MS
Study Chair
Topcon Corporation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials